2 Best Biotech Stocks to Buy in November

Biotech stocks appear to be poised for a strong showing in November for a host of reasons. First and foremost, the industry's biggest headwind this year -- drug pricing reform -- was conspicuously left out of the social spending bill recently released by the White House. Second, the latest earnings reports from top big pharma companies like Merck have been better than expected so far. Lastly, scores of drugmakers are slated to release key clinical and regulatory updates this month.

Which biotech stocks could be the belles of the ball in November? Bionano Genomics (NASDAQ: BNGO) and Ocugen (NASDAQ: OCGN) are two names that growth-oriented investors should definitely have on the radars this month. Here's why.

Image source: Getty Images.

Source Fool.com